,datetime,title,source,link,sentiment_class,sentiment_score
0,1/23/2018 9:05:00 AM,"Teva Pharmaceutical Industries Ltd -- Moody's: European generic drug market growth to continue into 2020 on patent expiries, rising usage",Moodys,/news/bonds/teva-pharmaceutical-industries-ltd-moody-s-european-generic-drug-market-growth-to-continue-into-2020-on-patent-expiries-rising-usage-1013685343,negative,0.9475629329681396
1,2/21/2018 5:07:00 PM,Cota Announces $40 Million Series C Financing to Advance its Cota Nodal Address™ Classification System and Real-World Evidence and Analytics Platforms,PR Newswire,/news/stocks/cota-announces-40-million-series-c-financing-to-advance-its-cota-nodal-address-classification-system-and-real-world-evidence-and-analytics-platforms-1016592620,negative,0.8487852215766907
2,3/12/2018 6:01:00 PM,MDA Collaborates with IQVIA to Expand Disease Registry into the New MOVR Data Hub,PR Newswire,/news/stocks/mda-collaborates-with-iqvia-to-expand-disease-registry-into-the-new-movr-data-hub-1018623278,positive,0.6139110922813416
3,5/2/2018 1:21:08 PM,BRIEF-Iqvia Holdings Q1 GAAP Earnings Per Share $0.32,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/GxqUv5JTtvo/brief-iqvia-holdings-q1-gaap-earnings-per-share-0-32-idUSASC09YXD,positive,0.6772704124450684
4,5/16/2018 6:50:15 PM,FDA finds inaccuracy in IQVIA sales data on some opioids,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/GxOcnW7IP24/fda-finds-inaccuracy-in-iqvia-sales-data-on-some-opioids-idUSL3N1SN5ES,neutral,0.9564414024353027
5,5/16/2018 7:40:34 PM,UPDATE 1-FDA reports inaccuracy in IQVIA opioid sales data,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/N2O-CmtPxno/update-1-fda-reports-inaccuracy-in-iqvia-opioid-sales-data-idUSL3N1SN5FN,neutral,0.9695584177970886
6,5/16/2018 9:38:50 PM,UPDATE 2-FDA reports inaccuracy in IQVIA data on opioids,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/F5yxfB233UU/update-2-fda-reports-inaccuracy-in-iqvia-data-on-opioids-idUSL3N1SN5FN,neutral,0.9700512290000916
7,5/30/2018 5:40:00 PM,IQVIA Inc. -- Moody's assigns Ba1 ratings to IQVIA's new senior secured credit facilities,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba1-ratings-to-iqvia-s-new-senior-secured-credit-facilities-1025862335,negative,0.523491382598877
8,7/22/2018 3:01:31 PM,IQVIA earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-quarter-earnings-preview-q2-1027387854,positive,0.9325198531150818
9,9/4/2018 10:18:00 PM,IQVIA Inc. -- Moody's affirms IQVIA's Ba2 CFR; outlook revised to stable,Moodys,/news/bonds/iqvia-inc-moody-s-affirms-iqvia-s-ba2-cfr-outlook-revised-to-stable-1027507498,negative,0.8886433243751526
10,9/4/2018 10:26:00 PM,IQVIA Inc. -- Moody's affirms IQVIA's Ba2 CFR; outlook revised to stable,Moodys,/news/bonds/iqvia-inc-moody-s-affirms-iqvia-s-ba2-cfr-outlook-revised-to-stable-1027507510,negative,0.8886433243751526
11,10/20/2018 3:01:18 PM,What Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-q3-earnings-preview-1027635536,positive,0.9339121580123901
12,2/12/2019 3:03:10 PM,Here's what to expect from IQVIA's earnings report,Markets Insider Automation,/news/stocks/iqvia-stock-price-q4-earnings-preview-1027945411,positive,0.9314884543418884
13,4/22/2019 10:13:00 PM,IQVIA Inc. -- Moody's announces completion of a periodic review of ratings of IQVIA Inc.,Moodys,/news/bonds/iqvia-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-iqvia-inc-1028127294,positive,0.8536259531974792
14,4/29/2019 3:02:38 PM,IQVIA earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-stock-q1-earnings-preview-1028148796,positive,0.9325198531150818
15,5/7/2019 2:36:00 PM,IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba3-rating-to-iqvia-s-new-senior-unsecured-notes-1028176364,positive,0.65336674451828
16,7/22/2019 3:01:35 PM,IQVIA earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-stock-quarter-earnings-preview-q2-1028371975,positive,0.9325198531150818
17,7/29/2019 2:34:00 PM,IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba3-rating-to-iqvia-s-new-senior-unsecured-notes-1028393613,positive,0.65336674451828
18,8/6/2019 1:38:09 PM,3 Keys to Investing in Next-Gen Healthcare Stocks,InvestorPlace,/news/stocks/investing-next-gen-healthcare-stocks-1028422576,positive,0.8820910453796387
19,9/5/2019 9:31:37 AM,"3 Big Stock Charts for Thursday: Xilinx, Norfolk Southern and Iqvia Holdings",InvestorPlace,/news/stocks/stock-charts-of-xlnx-nsc-and-iqv-are-each-knocking-on-the-door-of-what-could-turn-into-a-trade-worthy-move-1028504041,positive,0.92082279920578
20,2/11/2020 3:02:13 PM,IQVIA is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/iqvia-q4-quarterly-earnings-preview-1028893619,positive,0.9412426948547363
21,2/12/2020 1:08:28 PM,IQVIA beats Q4 consensus,Seeking Alpha,https://seekingalpha.com/news/3541000-iqvia-beats-q4-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5090262293815613
22,2/12/2020 1:34:27 PM,IQVIA Holdings Inc. Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q4-adjusted-earnings-beat-estimates-1028897902,negative,0.8863652944564819
23,2/12/2020 1:52:14 PM,IQVIA Holdings Guides FY20 In Line With Estimates - Quick Facts ,RTTNews,/news/stocks/iqvia-holdings-guides-fy20-in-line-with-estimates-quick-facts-1028897975,negative,0.5110099911689758
24,3/9/2020 8:32:00 PM,IQVIA Inc. -- Moody's announces completion of a periodic review of ratings of IQVIA Inc.,Moodys,/news/bonds/iqvia-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-iqvia-inc-1028978070,positive,0.8536259531974792
25,3/12/2020 5:40:00 PM,IQVIA Inc. -- Moody's assigns Ba1 rating to IQVIA's new term loan A,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba1-rating-to-iqvia-s-new-term-loan-a-1028990903,positive,0.6470663547515869
26,4/27/2020 3:01:50 PM,Here's what Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-q1-earnings-preview-1029132981,positive,0.9345874190330505
27,4/28/2020 12:06:43 PM,IQVIA lowers guidance due to COVID-19 impact,Seeking Alpha,https://seekingalpha.com/news/3565213-iqvia-lowers-guidance-due-to-covidminus-19-impact?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9269062280654907
28,4/28/2020 1:27:41 PM,IQVIA Holdings Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q1-adjusted-earnings-beat-estimates-1029137643,negative,0.8790900707244873
29,4/28/2020 1:51:10 PM,IQVIA Revises Full Year Guidance - Quick Facts ,RTTNews,/news/stocks/iqvia-revises-full-year-guidance-quick-facts-1029137766,positive,0.9307750463485718
30,5/20/2020 1:32:52 PM,Iqvia to manage study evaluating malaria drug for preventing COVID-19,Seeking Alpha,https://seekingalpha.com/news/3576335-iqvia-to-manage-study-evaluating-malaria-drug-for-preventing-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5985028743743896
31,6/9/2020 3:23:00 PM,IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba3-rating-to-iqvia-s-new-senior-unsecured-notes-1029293124,positive,0.65336674451828
32,6/11/2020 8:02:28 AM,IQVIA prices €711M debt offering,Seeking Alpha,https://seekingalpha.com/news/3582155-iqvia-prices-711m-debt-offering?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9439476728439331
33,7/14/2020 2:13:00 PM,"IQVIA, AstraZeneca Join To Accelerate Development Of Potential COVID-19 Vaccine ",RTTNews,/news/stocks/iqvia-astrazeneca-join-to-accelerate-development-of-potential-covid-19-vaccine-1029391907,negative,0.8552783131599426
34,7/15/2020 8:58:10 AM,"AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch ",RTTNews,/news/stocks/azn-iqv-team-up-to-accelerate-covid-19-vaccine-work-rigl-s-itp-drug-repurposed-imv-on-watch-1029395660,negative,0.7140966057777405
35,7/22/2020 4:52:46 AM,Biogen Appoints Michael McDonnell As EVP And CFO ,RTTNews,/news/stocks/biogen-appoints-michael-mcdonnell-as-evp-and-cfo-1029417049,positive,0.9382873773574829
36,7/22/2020 1:11:35 PM,IQVIA Holdings Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q2-adjusted-earnings-beat-estimates-1029419376,negative,0.8557157516479492
37,7/22/2020 1:25:24 PM,IQVIA Raises Full-year Guidance - Quick Facts ,RTTNews,/news/stocks/iqvia-raises-full-year-guidance-quick-facts-1029419402,positive,0.8374642729759216
38,10/19/2020 3:01:25 PM,IQVIA is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-q3-earnings-preview-stock-1029693628,positive,0.9357954263687134
39,10/19/2020 4:12:01 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3623312-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
40,10/19/2020 5:52:46 PM,IQVIA Q3 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3623349-iqvia-q3-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8083778619766235
41,10/20/2020 11:06:52 AM,"IQVIA EPS beats by $0.09, beats on revenue; raised guidance for FY20 & provides FY21 guidance",Seeking Alpha,https://seekingalpha.com/news/3623564-iqvia-eps-beats-0_09-beats-on-revenue-raised-guidance-for-fy20-provides-fy21-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9366887807846069
42,10/20/2020 11:37:28 AM,"Iqvia up 4% on Q3 beat, guidance raise",Seeking Alpha,https://seekingalpha.com/news/3623579-iqvia-up-4-on-q3-beat-guidance-raise?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9543861746788025
43,10/20/2020 1:31:16 PM,IQVIA Holdings Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q3-adjusted-earnings-beat-estimates-1029697961,negative,0.8622209429740906
44,12/14/2020 3:33:00 PM,Astrazeneca/Alexion deal impacts IQVIA: BofA,Seeking Alpha,https://seekingalpha.com/news/3644086-astrazeneca-alexion-deal-impacts-iqvia-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6566653847694397
45,12/16/2020 2:22:19 PM,IQVIA To Collaborate With Servier On R&D Transformation Program - Quick Facts ,RTTNews,/news/stocks/iqvia-to-collaborate-with-servier-on-r-d-transformation-program-quick-facts-1029898249,negative,0.7381558418273926
46,12/18/2020 8:42:01 PM,Stocks That Hit 52-Week Highs On Friday,Benzinga,/news/stocks/stocks-that-hit-52-week-highs-on-friday-1029909493,positive,0.7065430879592896
47,1/2/2021 7:52:28 PM,"Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More",Benzinga,/news/stocks/notable-insider-buys-of-the-past-week-danimer-scientific-cheniere-energy-partners-and-more-1029928716,positive,0.9135705828666687
48,2/5/2021 11:03:00 PM,IQVIA Inc. -- Moody's announces completion of a periodic review of ratings of IQVIA Inc.,Moodys,/news/bonds/iqvia-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-iqvia-inc-1030049910,positive,0.8536259531974792
49,2/8/2021 3:02:01 PM,IQVIA is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/iqvia-q4-earnings-preview-stock-1030055442,positive,0.9412426948547363
50,2/9/2021 4:57:58 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3660029-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855887770652771
51,2/9/2021 5:01:21 PM,IQVIA Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3660035-iqvia-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8566805124282837
52,2/10/2021 12:05:55 PM,"IQVIA EPS beats by $0.10, beats on revenue, raises FY21 guidance",Seeking Alpha,https://seekingalpha.com/news/3660432-iqvia-eps-beats-by-010-beats-on-revenue-raises-fy21-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.909857451915741
53,2/10/2021 12:49:22 PM,"IQVIA shares rise on FY forecast raise, Q4 beat",Seeking Alpha,https://seekingalpha.com/news/3660476-iqvia-shares-rise-on-fy-forecast-raise-q4-beat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9058701992034912
54,2/10/2021 1:19:44 PM,IQVIA Holdings Inc. Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q4-adjusted-earnings-beat-estimates-1030066062,negative,0.8863652944564819
55,2/10/2021 1:21:41 PM,IQVIA Holdings Boosts FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/iqvia-holdings-boosts-fy21-outlook-quick-facts-1030066091,negative,0.9019439220428467
56,2/16/2021 10:13:10 AM,IQVIA to raise €1.45B debt capital to redeem 3.250% senior notes due 2025.,Seeking Alpha,https://seekingalpha.com/news/3662027-iqvia-to-raise-145b-debt-capital-to-redeem-3250-senior-notes-due-2025?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6596999764442444
57,2/16/2021 1:29:00 PM,IQVIA Inc. -- Moody's assigns Ba3 ratings to IQVIA's new senior unsecured notes,Moodys,/news/bonds/iqvia-inc-moody-s-assigns-ba3-ratings-to-iqvia-s-new-senior-unsecured-notes-1030086568,positive,0.751421332359314
58,2/17/2021 10:00:56 PM,IQVIA prices senior notes offering,Seeking Alpha,https://seekingalpha.com/news/3663206-iqvia-prices-senior-notes-offering?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9329735636711121
59,3/3/2021 4:02:31 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-3-2021-1030145958,neutral,0.5482129454612732
60,3/8/2021 4:04:40 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-8-2021-1030160061,neutral,0.584946870803833
61,4/1/2021 11:12:09 AM,Quest Diagnostics divests ownership interests in Q² Solutions to IQVIA,Seeking Alpha,https://seekingalpha.com/news/3678447-quest-diagnostics-divests-ownership-interests-in-q-solutions-to-iqvia?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.941422164440155
62,4/1/2021 1:38:13 PM,IQVIA Acquires Q2 Solutions ,RTTNews,/news/stocks/iqvia-acquires-q2-solutions-1030268510,positive,0.9458838701248169
63,4/16/2021 4:08:04 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 16, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-16-2021-1030312892,neutral,0.5975582599639893
64,4/20/2021 11:01:54 PM,News shakeup has Baird re-sorting healthcare contract research picks,Seeking Alpha,https://seekingalpha.com/news/3683747-news-shakeup-has-baird-re-sorting-healthcare-contract-research-picks?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6933383941650391
65,4/21/2021 4:51:00 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3684052-notable-earnings-before-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8825733065605164
66,4/21/2021 5:11:19 PM,IQVIA Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3684076-iqvia-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7986424565315247
67,4/21/2021 7:35:11 PM,"UBS bullish on Q1 growth for life sciences & diagnostic tools; picks IQVIA, Catalent and Avantor as top ideas",Seeking Alpha,https://seekingalpha.com/news/3684160-ubs-bullish-on-q1-growth-for-life-sciences-diagnostic-tools-cites-perkinelmer-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9164416193962097
68,4/22/2021 11:03:27 AM,"IQVIA EPS beats by $0.32, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3684438-iqvia-eps-beats-0_32-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.559149980545044
69,4/22/2021 1:12:43 PM,IQVIA Holdings Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q1-adjusted-earnings-beat-estimates-1030332671,negative,0.8790900707244873
70,4/22/2021 2:26:40 PM,IQVIA surges on Q1 earnings beat and guidance raise,Seeking Alpha,https://seekingalpha.com/news/3684625-iqvia-surges-on-quarter-earnings-beat-and-guidance-raise-for-2021?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9184505343437195
71,4/29/2021 6:10:51 PM,7 Health-Focused ETFs To Buy Now For the Post-Covid Future,InvestorPlace,/news/stocks/7-health-focused-etfs-to-buy-now-for-the-post-covid-future-1030366420,positive,0.847977340221405
72,5/10/2021 3:25:16 PM,U.S. District Court Issues Favorable Decision To IQVIA In Litigation With Veeva - Quick Facts ,RTTNews,/news/stocks/u-s-district-court-issues-favorable-decision-to-iqvia-in-litigation-with-veeva-quick-facts-1030409678,negative,0.9265410304069519
73,5/12/2021 12:07:36 PM,ProtoKinetix and IQVIA partner to support development of eye treatment,Seeking Alpha,https://seekingalpha.com/news/3695187-protokinetix-and-iqvia-partner-to-support-development-of-eye-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7266602516174316
74,5/14/2021 9:25:57 PM,How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre,Benzinga,/news/etf/how-to-trade-these-7-healthcare-stocks-and-etf-says-2ndskiesforex-s-chris-capre-1030431878,positive,0.9189494252204895
75,5/15/2021 10:45:29 PM,The 'new momentum' stocks to watch: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3696874-the-new-momentum-stocks-to-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.905489444732666
76,5/24/2021 1:35:50 PM,Myriad Genetics To Sell Myriad RBM To Q2 Solutions - Quick Facts ,RTTNews,/news/stocks/myriad-genetics-to-sell-myriad-rbm-to-q2-solutions-quick-facts-1030458286,positive,0.9226137399673462
77,6/28/2021 3:39:55 PM,Let's make a deal? BTIG screens top merger targets,Seeking Alpha,https://seekingalpha.com/news/3710588-lets-make-a-deal-btig-screens-top-takeover-targets?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9172496199607849
78,7/1/2021 8:21:16 PM,Myriad Genetics completes sale of laboratory unit to IQVIA subsidiary,Seeking Alpha,https://seekingalpha.com/news/3712196-myriad-genetics-completes-sales-of-laboratory-unit-to-iqvia-subsidiary?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9191534519195557
79,7/13/2021 7:42:39 PM,Where IQVIA Holdings Stands With Analysts,Benzinga,/news/stocks/where-iqvia-holdings-stands-with-analysts-1030602977,positive,0.9291821122169495
80,7/25/2021 3:01:45 PM,Here's what Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-q2-quarterly-earnings-preview-stock-1030641621,positive,0.9345874190330505
81,7/26/2021 2:08:25 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3719052-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
82,7/27/2021 11:03:29 AM,"IQVIA EPS beats by $0.05, beats on revenue, raises FY21 outlook",Seeking Alpha,https://seekingalpha.com/news/3719495-iqvia-eps-beats-by-005-beats-on-revenue-raised-fy21-outlook?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9176626205444336
83,7/27/2021 1:27:34 PM,IQVIA Holdings Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q2-adjusted-earnings-beat-estimates-1030649576,negative,0.8557157516479492
84,7/27/2021 1:30:04 PM,IQVIA Holdings Boosts FY21 Outlook - Quick Facts ,RTTNews,/news/stocks/iqvia-holdings-boosts-fy21-outlook-quick-facts-1030649575,negative,0.9019439220428467
85,7/29/2021 6:02:41 PM,What 13 Analyst Ratings Have To Say About IQVIA Holdings,Benzinga,/news/stocks/what-13-analyst-ratings-have-to-say-about-iqvia-holdings-1030663550,positive,0.9381362795829773
86,8/6/2021 1:27:09 PM,Dan Loeb's Third Point discusses new stake in RH; says Disney can do more in streaming (update),Seeking Alpha,https://seekingalpha.com/news/3727013-dan-loebs-third-point-takes-new-stake-in-rh?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8864023685455322
87,9/8/2021 3:26:06 PM,IQVIA Collaborates With HealthCore To Advance Research Using Real-World Data ,RTTNews,/news/stocks/iqvia-collaborates-with-healthcore-to-advance-research-using-real-world-data-1030787399,positive,0.8115342259407043
88,9/10/2021 7:40:00 PM,Where IQVIA Holdings Stands With Analysts,Benzinga,/news/stocks/where-iqvia-holdings-stands-with-analysts-1030793310,positive,0.9291821122169495
89,9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122,negative,0.8988337516784668
90,9/14/2021 2:17:52 PM,Why Are NRx Pharma Shares Moving Higher On Tuesday Premarket?,Benzinga,/news/stocks/why-are-nrx-pharma-shares-moving-higher-on-tuesday-premarket-1030798286,positive,0.5143742561340332
91,10/15/2021 1:29:31 PM,10 Biggest Price Target Changes For Friday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-friday-1030869242,positive,0.7916322350502014
92,10/19/2021 3:01:28 PM,Here's what Wall Street expects from IQVIA's earnings report,Markets Insider Automation,/news/stocks/iqvia-q3-quarterly-earnings-preview-stock-1030877510,positive,0.9204581379890442
93,10/20/2021 3:17:24 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3755573-notable-earnings-before-thursdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8825733065605164
94,10/21/2021 1:13:57 PM,IQVIA Holdings Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q3-adjusted-earnings-beat-estimates-1030885230,negative,0.8622209429740906
95,10/21/2021 1:59:25 PM,IQVIA Raises Annual Outlook Better Than Analysts' View - Update ,RTTNews,/news/stocks/iqvia-raises-annual-outlook-better-than-analysts-view-update-1030885407,negative,0.9507201313972473
96,10/22/2021 6:34:48 PM,Where IQVIA Holdings Stands With Analysts,Benzinga,/news/stocks/where-iqvia-holdings-stands-with-analysts-1030889665,positive,0.9291821122169495
97,11/16/2021 7:55:52 PM,IQVIA reaches a 52-week high following investor conference,Seeking Alpha,https://seekingalpha.com/news/3771599-iqvia-reaches-a-52-week-high-following-investor-conference?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7664227485656738
98,11/17/2021 12:56:09 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030983776,positive,0.8142690658569336
99,11/17/2021 6:07:33 PM,What 8 Analyst Ratings Have To Say About IQVIA Holdings,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-iqvia-holdings-1030985298,positive,0.9407763481140137
100,1/27/2022 10:00:09 PM,"Biotech ETFs plunge in the first month of 2022, some down nearly 30%",Seeking Alpha,https://seekingalpha.com/news/3792817-biotech-etfs-plunge-in-the-first-month-of-2022-some-down-nearly-30?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.974712073802948
101,2/8/2022 12:04:35 PM,"UBS debuts tactical screen for selloff opportunities, cuts Meta off two lists",Seeking Alpha,https://seekingalpha.com/news/3796135-ubs-debuts-tactical-screen-for-selloff-opportunities-cuts-meta-off-two-lists?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.926971971988678
102,2/14/2022 3:01:13 PM,IQVIA earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/iqvia-q4-earnings-preview-1031191655,positive,0.9205178022384644
103,2/14/2022 3:10:46 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3799589-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
104,2/14/2022 5:46:45 PM,IQVIA Q4 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3799698-iqvia-q4-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8142469525337219
105,2/15/2022 12:01:39 PM,"IQVIA Non-GAAP EPS of $2.55 beats by $0.12, revenue of $3.64B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3799962-iqvia-non-gaap-eps-of-2_55-beats-0_12-revenue-of-3_64b-beats-30m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8146952986717224
106,2/15/2022 1:11:39 PM,"IQVIA Holdings Inc. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q4-profit-increases-beats-estimates-1031195172,negative,0.9396405220031738
107,2/15/2022 1:32:06 PM,IQVIA Holdings Boosts FY22 Adj. EPS Outlook - Quick Facts ,RTTNews,/news/stocks/iqvia-holdings-boosts-fy22-adj-eps-outlook-quick-facts-1031195282,negative,0.8172329068183899
108,2/15/2022 4:33:55 PM,IQVIA stock falls despite top line beat driven by 167% increase in net income,Seeking Alpha,https://seekingalpha.com/news/3800205-iqvia-stock-falls-despite-top-line-beat-driven-167-increase-net-income?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9661290645599365
109,2/18/2022 1:20:17 PM,10 Biggest Price Target Changes For Friday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-friday-1031208338,positive,0.7916322350502014
110,3/7/2022 4:05:06 PM,Analyst Ratings For IQVIA Hldgs,Benzinga,/news/stocks/analyst-ratings-for-iqvia-hldgs-1031259826,positive,0.913325309753418
111,4/20/2022 5:40:24 PM,Iqvia price target lowered at BofA on forex concerns,Seeking Alpha,https://seekingalpha.com/news/3824871-iqv-stock-gains-even-after-price-target-lowered-by-bofa-on-forex-concerns?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7277172803878784
112,4/23/2022 8:00:00 PM,COVID therapies and vaccines propel rise in spending on medicines in 2021,Seeking Alpha,https://seekingalpha.com/news/3825965-covid-therapies-and-vaccines-propel-rise-in-spending-on-medicines-in-2021?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9413689374923706
113,4/25/2022 1:53:49 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1031379838,positive,0.7998325824737549
114,4/25/2022 4:07:25 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-25-2022-1031380608,positive,0.5321393609046936
115,4/25/2022 5:07:39 PM,Syneos Health hits a 52-week low after Jefferies downgrade,Seeking Alpha,https://seekingalpha.com/news/3826294-synh-stock-hits-52-week-low-after-jefferies-downgrade?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9631615281105042
116,4/25/2022 5:23:34 PM,"Wells Fargo downgrades Thermo Fisher to underweight on ""expensive"" valuation",Seeking Alpha,https://seekingalpha.com/news/3826315-thermo-fisher-downgraded-to-underweight-on-valuation-at-wells-fargo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9538577198982239
117,4/25/2022 9:03:36 PM,Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/analyst-ratings-for-iqvia-hldgs-1031381315,positive,0.913325309753418
118,4/26/2022 2:51:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3826832-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855887770652771
119,4/26/2022 3:01:13 PM,Here's what Wall Street expects from IQVIA's earnings report,Markets Insider Automation,/news/stocks/iqvia-stock-price-q1-earnings-preview-1031384924,positive,0.9204581379890442
120,4/26/2022 3:46:23 PM,Medpace drags rivals after unchanged 2022 guidance,Seeking Alpha,https://seekingalpha.com/news/3826871-medpace-drags-rivals-after-unchanged-2022-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9190753102302551
121,4/26/2022 5:53:20 PM,IQVIA Q1 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3827032-iqvia-q1-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8808495998382568
122,4/27/2022 11:03:38 AM,"IQVIA Non-GAAP EPS of $2.47 beats by $0.05, revenue of $3.57B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3827441-iqvia-non-gaap-eps-of-2_47-beats-0_05-revenue-of-3_57b-beats-30m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7824888825416565
123,4/27/2022 1:43:58 PM,IQVIA Updates 2022 Revenue Guidance ,RTTNews,/news/stocks/iqvia-updates-2022-revenue-guidance-1031390599,positive,0.9204128980636597
124,4/27/2022 2:26:05 PM,"IQVIA Holdings Inc. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q1-profit-increases-beats-estimates-1031390935,negative,0.9380467534065247
125,4/29/2022 3:03:09 PM,Iqvia upgraded at Piper; says end market concerns are overblown,Seeking Alpha,https://seekingalpha.com/news/3829498-iqv-stock-up-on-piper-sandler-upgrade?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.899331271648407
126,4/29/2022 4:03:33 PM,"Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-april-29-2022-1031402884,positive,0.5348138213157654
127,5/24/2022 11:08:58 AM,Amphastar announces FDA approval of generic for Astellas’ Lexiscan,Seeking Alpha,https://seekingalpha.com/news/3842107-amph-stock-in-focus-after-fda-approval-of-generic-for-astellas-lexiscan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6459357142448425
128,5/24/2022 2:53:45 PM,"CROs ICON, IQVIA, and Syneos Health initiated at buy at Guggenheim",Seeking Alpha,https://seekingalpha.com/news/3842270-contract-research-organization-icon-iqvia-and-syneos-health-initiated-at-buy-at-guggenheim?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9090340733528137
129,5/24/2022 3:02:21 PM,Where IQVIA Hldgs Stands With Analysts,Benzinga,/news/stocks/where-iqvia-hldgs-stands-with-analysts-1031485116,positive,0.894524872303009
130,5/24/2022 4:04:33 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-24-2022-1031485498,positive,0.5132130980491638
131,6/16/2022 12:39:01 PM,Walgreens launches clinical trial business,Seeking Alpha,https://seekingalpha.com/news/3849214-walgreens-launches-clinical-trial-business?utm_source=businessinsider&utm_medium=referral,positive,0.8805608153343201
132,6/27/2022 10:15:06 AM,7 Biotech Stocks With Key Catalysts Coming in July,InvestorPlace,/news/stocks/7-biotech-stocks-with-key-catalysts-coming-in-july-1031551243,negative,0.5154504776000977
133,7/5/2022 6:16:38 PM,3 Biotech Stocks to Sell Now,InvestorPlace,/news/stocks/biotech-stocks-to-sell-1031568378,positive,0.9156688451766968
134,7/13/2022 4:11:00 PM,What 5 Analyst Ratings Have To Say About IQVIA Hldgs,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-iqvia-hldgs-1031584863,positive,0.9437293410301208
135,7/15/2022 4:18:29 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-15-2022-1031590571,positive,0.5333232283592224
136,7/20/2022 3:01:13 PM,What Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-stock-price-q2-earnings-preview-1031601088,positive,0.9339121580123901
137,7/20/2022 3:08:39 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3858592-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8825733065605164
138,7/21/2022 11:07:44 AM,"IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance",Seeking Alpha,https://seekingalpha.com/news/3858968-iqvia-non-gaap-eps-of-244-beats-by-006-revenue-of-354b-beats-by-50m-raises-fy22-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.8955742716789246
139,7/21/2022 1:19:21 PM,"IQVIA Holdings Inc. Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q2-profit-increases-beats-estimates-1031604254,negative,0.9397760033607483
140,7/21/2022 1:42:33 PM,IQVIA Holdings Adjusts FY22 Outlook To Reflect FX Impact - Update ,RTTNews,/news/stocks/iqvia-holdings-adjusts-fy22-outlook-to-reflect-fx-impact-update-1031604343,positive,0.5995479226112366
141,7/22/2022 8:56:08 AM,"DGX Boosts FY22 Outlook, NURO On Watch, PSTV To Present ReSPECT-GBM Data In Sep. ",RTTNews,/news/stocks/dgx-boosts-fy22-outlook-nuro-on-watch-pstv-to-present-respect-gbm-data-in-sep-1031606893,negative,0.7740456461906433
142,7/22/2022 10:30:54 AM,7 Growth Stocks to Buy on the Dip,InvestorPlace,/news/stocks/growth-stocks-to-buy-on-the-dip-1031607316,positive,0.8326894640922546
143,7/23/2022 6:55:04 PM,UBS lists top conviction stock ideas for its favorite sectors,Seeking Alpha,https://seekingalpha.com/news/3859827-ubs-lists-top-conviction-stock-ideas-for-its-favorite-sectors?utm_source=businessinsider&utm_medium=referral,positive,0.9275354146957397
144,7/31/2022 6:57:28 PM,UBS reveals its highest conviction stock picks for the rest of 2022,Seeking Alpha,https://seekingalpha.com/news/3863507-ubs-reveals-its-highest-conviction-stock-picks-for-the-rest-of-2022?utm_source=businessinsider&utm_medium=referral,negative,0.8287612795829773
145,8/11/2022 9:36:27 AM,"GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US",Seeking Alpha,https://seekingalpha.com/news/3871307-gsk-iqvia-launch-vaccine-track-platform-to-highlight-vaccine-trends-publicly-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.7957823872566223
146,8/15/2022 9:37:55 PM,"Dan Loeb's Third Point takes new stakes in Colgate, Antero, exits S&P Global",Seeking Alpha,https://seekingalpha.com/news/3873302-dan-loebs-third-point-takes-new-stakes-in-colgate-antero-exits-sp-global?utm_source=businessinsider&utm_medium=referral,positive,0.919777512550354
147,8/25/2022 3:53:48 PM,"Bio-Rad, IQVIA, Bio-Techne among top picks at Credit Suisse",Seeking Alpha,https://seekingalpha.com/news/3876720-rad-stock-tech-stock-iqv-stock-gain-as-credit-suisse-names-top-picks?utm_source=businessinsider&utm_medium=referral,negative,0.5390989780426025
148,8/25/2022 4:33:31 PM,5 Analysts Have This to Say About IQVIA Hldgs,Benzinga,/news/stocks/5-analysts-have-this-to-say-about-iqvia-hldgs-1031706292,positive,0.92631596326828
149,8/25/2022 4:34:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-august-25-2022-1031706291,positive,0.5189008116722107
150,8/25/2022 6:04:11 PM,What 5 Analyst Ratings Have To Say About IQVIA Hldgs,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-iqvia-hldgs-1031706517,positive,0.9437293410301208
151,9/12/2022 7:08:43 PM,6 Analysts Have This to Say About IQVIA Hldgs,Benzinga,/news/stocks/6-analysts-have-this-to-say-about-iqvia-hldgs-1031738032,positive,0.925869345664978
152,9/12/2022 9:09:37 PM,Expert Ratings for IQVIA Hldgs,Benzinga,/news/stocks/expert-ratings-for-iqvia-hldgs-1031738178,positive,0.8439691662788391
153,10/6/2022 1:34:50 PM,Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67%,Benzinga,/news/stocks/tesla-to-370-plus-hc-wainwright-slashes-pt-on-this-stock-by-67-1031787024,positive,0.6047031879425049
154,10/25/2022 3:01:13 PM,Here's what Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-stock-price-quarter-earnings-preview-q3-1031832876,positive,0.9345874190330505
155,10/25/2022 3:10:05 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3894799-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.855887770652771
156,10/25/2022 4:50:54 PM,IQVIA Q3 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3894922-iqvia-q3-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8728036284446716
157,10/26/2022 11:11:09 AM,"IQVIA Non-GAAP EPS of $2.48 beats by $0.10, revenue of $3.56B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/3895364-iqvia-non-gaap-eps-of-2_48-beats-0_10-revenue-of-3_56b-beats-20m?utm_source=businessinsider&utm_medium=referral,positive,0.783193826675415
158,10/26/2022 1:30:27 PM,"IQVIA Holdings Inc. Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q3-profit-increases-beats-estimates-1031837531,negative,0.9386873841285706
159,10/27/2022 12:40:34 PM,"Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Thermo Fisher (TMO) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-align-tech-algn-thermo-fisher-tmo-and-iqvia-holdings-iqv-1031843383,positive,0.9117166996002197
160,10/27/2022 4:00:49 PM,5 Analysts Have This to Say About IQVIA Hldgs,Benzinga,/news/stocks/5-analysts-have-this-to-say-about-iqvia-hldgs-1031844081,positive,0.92631596326828
161,10/27/2022 4:22:15 PM,General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday,Benzinga,/news/stocks/general-electric-to-rally-around-14-here-are-5-other-price-target-changes-for-thursday-1031844164,positive,0.9275838136672974
162,10/28/2022 2:11:50 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Thermo Fisher (TMO), IQVIA Holdings (IQV) and Editas Medicine (EDIT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-thermo-fisher-tmo-iqvia-holdings-iqv-and-editas-medicine-edit-1031845751,neutral,0.9150316715240479
163,10/31/2022 4:25:29 AM,SVB Securities Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/svb-securities-remains-a-buy-on-iqvia-holdings-iqv-1031850975,positive,0.9524787664413452
164,10/31/2022 4:25:57 AM,Mizuho Securities Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/mizuho-securities-remains-a-buy-on-iqvia-holdings-iqv-1031850966,positive,0.9500922560691833
165,11/14/2022 12:10:54 PM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), TG Therapeutics (TGTX) and Gossamer Bio (GOSS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-tg-therapeutics-tgtx-and-gossamer-bio-goss-1031909694,positive,0.917746901512146
166,11/17/2022 1:02:19 PM,Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/analyst-ratings-for-iqvia-hldgs-1031921731,positive,0.913325309753418
167,11/17/2022 1:12:09 PM,Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings,Benzinga,/news/stocks/target-to-rally-29-plus-this-analyst-predicts-245-for-iqvia-holdings-1031921803,negative,0.8852123618125916
168,11/17/2022 2:01:27 PM,Where IQVIA Hldgs Stands With Analysts,Benzinga,/news/stocks/where-iqvia-hldgs-stands-with-analysts-1031921988,positive,0.894524872303009
169,11/17/2022 4:13:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-17-2022-1031922777,neutral,0.49820592999458313
170,12/1/2022 5:38:36 AM,"MRNA, BIIB, or IQV: Which Biotech Stock Earns the Street’s “Strong Buy” Rating?",TipRanks,/news/stocks/mrna-biib-or-iqv-which-biotech-stock-earns-the-street-s-strong-buy-rating-1031946927,positive,0.8603474497795105
171,12/6/2022 1:04:59 PM,Expert Ratings for IQVIA Hldgs,Benzinga,/news/stocks/expert-ratings-for-iqvia-hldgs-1031955048,positive,0.8439691662788391
172,12/6/2022 4:05:04 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-6-2022-1031955691,positive,0.5029008388519287
173,12/7/2022 3:00:54 PM,"Analysts Are Bullish on These Healthcare Stocks: Celldex (CLDX), IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-celldex-cldx-iqvia-holdings-iqv-1031958406,positive,0.6506418585777283
174,1/13/2023 5:00:23 PM,Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/analyst-ratings-for-iqvia-hldgs-1032017917,positive,0.913325309753418
175,1/16/2023 1:15:10 AM,Barclays Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-remains-a-buy-on-iqvia-holdings-iqv-1032018972,positive,0.9434985518455505
176,1/17/2023 12:25:25 PM,Barclays Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-remains-a-buy-on-iqvia-holdings-iqv-1032022512,positive,0.9434985518455505
177,1/17/2023 1:52:24 PM,World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday,Benzinga,/news/stocks/world-wrestling-entertainment-to-rally-around-12-here-are-10-other-analyst-forecasts-for-tuesday-1032022318,positive,0.909263551235199
178,1/22/2023 5:00:19 PM,Global drug spending to reach $1.9T by 2027 – IQVIA,Seeking Alpha,https://seekingalpha.com/news/3926554-global-drug-spending-reach-usd-two-trillion-2027-iqvia?utm_source=businessinsider&utm_medium=referral,negative,0.8150349855422974
179,1/27/2023 12:39:46 PM,Mizuho picks its top stocks for 2023,Seeking Alpha,https://seekingalpha.com/news/3928578-mizuho-picks-its-top-stocks-for-2023?utm_source=businessinsider&utm_medium=referral,positive,0.925223171710968
180,1/31/2023 2:56:08 PM,IQVIA and Alibaba Cloud to deliver commercial & clinical solutions in China,Seeking Alpha,https://seekingalpha.com/news/3929878-iqvia-and-alibaba-cloud-to-deliver-commercial-clinical-solutions-in-china?utm_source=businessinsider&utm_medium=referral,positive,0.8180637955665588
181,2/9/2023 3:01:13 PM,Here's what Wall Street expects from IQVIA's earnings report,Markets Insider Automation,/news/stocks/iqvia-q4-quarterly-earnings-preview-stock-1032083148,positive,0.9204581379890442
182,2/9/2023 4:59:48 PM,IQVIA Q4 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3934336-iqvia-q4-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8869616985321045
183,2/10/2023 12:10:23 PM,"IQVIA Non-GAAP EPS of $2.78 beats by $0.02, revenue of $3.74B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3934724-iqvia-non-gaap-eps-of-2_78-beats-0_02-revenue-of-3_74b-beats-30m?utm_source=businessinsider&utm_medium=referral,positive,0.7397875785827637
184,2/10/2023 1:05:56 PM,"IQVIA Holdings Inc. Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q4-profit-decreases-but-beats-estimates-1032086096,neutral,0.9628974795341492
185,2/10/2023 1:31:55 PM,IQVIA Issues 2023 Guidance ,RTTNews,/news/stocks/iqvia-issues-2023-guidance-1032086218,positive,0.943890392780304
186,2/10/2023 7:25:41 PM,IQVIA down despite quarterly beats on soft 2023 guidance,Seeking Alpha,https://seekingalpha.com/news/3934931-iqvia-down-despite-quarterly-beats-on-soft-2023-guidance?utm_source=businessinsider&utm_medium=referral,neutral,0.9675937294960022
187,2/13/2023 11:40:05 AM,"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), IQVIA Holdings (IQV) and Viatris (VTRS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-iqvia-holdings-iqv-and-viatris-vtrs-1032090836,positive,0.9209754467010498
188,2/13/2023 12:20:08 PM,"Analysts Are Bullish on Top Healthcare Stocks: Roivant Sciences (ROIV), IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-roivant-sciences-roiv-iqvia-holdings-iqv-1032090978,negative,0.5650308728218079
189,2/13/2023 12:35:19 PM,Cowen & Co. Sticks to Their Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/cowen-co-sticks-to-their-buy-rating-for-iqvia-holdings-iqv-1032091010,positive,0.8661050200462341
190,2/13/2023 1:10:23 PM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Globus Medical (GMED) and Bicycle Therapeutics (BCYC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-globus-medical-gmed-and-bicycle-therapeutics-bcyc-1032091108,positive,0.9064225554466248
191,2/13/2023 5:00:40 PM,Where IQVIA Hldgs Stands With Analysts,Benzinga,/news/stocks/where-iqvia-hldgs-stands-with-analysts-1032091714,positive,0.894524872303009
192,2/15/2023 5:05:15 AM,SVB Securities Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/svb-securities-remains-a-buy-on-iqvia-holdings-iqv-1032096536,positive,0.9524787664413452
193,2/15/2023 5:05:31 AM,Robert W. Baird Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/robert-w-baird-keeps-their-buy-rating-on-iqvia-holdings-iqv-1032096528,positive,0.9241735935211182
194,2/15/2023 5:13:24 AM,"Analysts Conflicted on These Healthcare Names: IQVIA Holdings (IQV), Reata Pharmaceuticals (RETA) and Roivant Sciences (ROIV)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-iqvia-holdings-iqv-reata-pharmaceuticals-reta-and-roivant-sciences-roiv-1032096683,neutral,0.7048758864402771
195,2/15/2023 7:11:38 PM,7 Hot Healthcare Stocks With the Potential to Outperform,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-with-the-potential-to-outperform-1032103825,negative,0.9004144668579102
196,2/27/2023 2:01:54 PM,MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/mannkind-to-rally-around-30-here-are-10-other-analyst-forecasts-for-monday-1032127583,positive,0.9095765352249146
197,3/17/2023 2:01:29 PM,What 6 Analyst Ratings Have To Say About IQVIA Hldgs,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-iqvia-hldgs-1032175766,positive,0.9454025626182556
198,3/17/2023 3:01:39 PM,"IQVIA, a new buy at Truist on differentiated contract research organization business",Seeking Alpha,https://seekingalpha.com/news/3948558-iqvia-a-new-buy-at-truist-on-differentiated-contract-research-organization-business?utm_source=businessinsider&utm_medium=referral,positive,0.8511984944343567
199,3/17/2023 4:00:49 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-17-2023-1032176100,neutral,0.507459282875061
200,3/28/2023 5:21:30 AM,"VRTX, BIIB, or IQV: Which Biotech Stock Could Deliver the Highest Return?",TipRanks,/news/stocks/vrtx-biib-or-iqv-which-biotech-stock-could-deliver-the-highest-return-1032195771,positive,0.9018274545669556
201,4/4/2023 7:00:41 PM,The Latest Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/the-latest-analyst-ratings-for-iqvia-hldgs-1032214650,positive,0.935731053352356
202,4/11/2023 8:30:18 PM,Quant Ratings Updated on 70 Stocks,InvestorPlace,/news/stocks/20230411-quant-ratings-1032225430,positive,0.923706591129303
203,4/26/2023 3:01:13 PM,What Wall Street expects from IQVIA's earnings,Markets Insider Automation,/news/stocks/iqvia-quarter-earnings-preview-q1-1032263694,positive,0.9339121580123901
204,4/26/2023 3:07:35 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3960517-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8825733065605164
205,4/26/2023 4:13:10 PM,IQVIA Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3960559-iqvia-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8717511892318726
206,4/27/2023 11:10:21 AM,"IQVIA Non-GAAP EPS of $2.45 beats by $0.04, revenue of $3.65B beats by $40M",Seeking Alpha,https://seekingalpha.com/news/3961213-iqvia-non-gaap-eps-of-2_45-beats-0_04-revenue-of-3_65b-beats-40m?utm_source=businessinsider&utm_medium=referral,positive,0.768231987953186
207,4/27/2023 1:59:10 PM,"IQVIA Holdings Inc. Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q1-profit-decreases-but-beats-estimates-1032268373,neutral,0.9640533328056335
208,4/27/2023 6:33:00 PM,"Iqvia, Icon lag contract research rivals after Q1 earnings",Seeking Alpha,https://seekingalpha.com/news/3961571-iqvia-stock-icon-stock-lag-contract-research-space-despite-q1-beats?utm_source=businessinsider&utm_medium=referral,neutral,0.7426392436027527
209,4/28/2023 8:25:52 AM,Barclays Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-iqvia-holdings-iqv-1032272671,positive,0.9224793314933777
210,4/28/2023 4:02:10 PM,Expert Ratings for IQVIA Hldgs,Benzinga,/news/stocks/expert-ratings-for-iqvia-hldgs-1032274106,positive,0.8439691662788391
211,4/28/2023 4:40:25 PM,"Analysts Offer Insights on Healthcare Companies: Baxter International (BAX), IQVIA Holdings (IQV) and Abcam (ABCM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-baxter-international-bax-iqvia-holdings-iqv-and-abcam-abcm-1032274624,positive,0.9226043224334717
212,5/1/2023 12:30:35 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032277994,negative,0.5521676540374756
213,5/1/2023 3:02:33 PM,"Analysts Are Bullish on Top Healthcare Stocks: Pliant Therapeutics (PLRX), IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-pliant-therapeutics-plrx-iqvia-holdings-iqv-1032278661,negative,0.644888162612915
214,5/1/2023 5:20:36 PM,Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and IQVIA Holdings (IQV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-resmed-rmd-and-iqvia-holdings-iqv-1032278995,positive,0.9168568849563599
215,5/2/2023 7:43:45 PM,FDA to broaden access to decentralized clinical trials,Seeking Alpha,https://seekingalpha.com/news/3963828-fda-to-broaden-access-decentralized-clinical-trials?utm_source=businessinsider&utm_medium=referral,negative,0.7559641003608704
216,5/2/2023 8:31:20 PM,Quant Ratings Updated on 122 Stocks,InvestorPlace,/news/stocks/20230502-quant-ratings-1032284093,positive,0.9266848564147949
217,5/7/2023 4:00:27 PM,Spending on weight loss drugs to rise 378% in 2023 – 2027: report,Seeking Alpha,https://seekingalpha.com/news/3966814-spending-weight-loss-drugs-wegovy-mounjaro-2023-2027?utm_source=businessinsider&utm_medium=referral,negative,0.9277639389038086
218,5/9/2023 7:23:46 PM,IQVIA under FTC investigation over digital ads acquisition - Politico,Seeking Alpha,https://seekingalpha.com/news/3968382-iqvia-under-ftc-investigation-digital-ads-acquisition?utm_source=businessinsider&utm_medium=referral,neutral,0.7036442160606384
219,5/15/2023 11:15:14 AM,ANI Pharma gains as FDA clears generics for Celontin and Fosamax,Seeking Alpha,https://seekingalpha.com/news/3971216-ani-pharma-stock-gains-on-fda-nod-for-celontin-and-fosamax-generics?utm_source=businessinsider&utm_medium=referral,negative,0.9229909777641296
220,5/15/2023 10:03:22 PM,"Druckenmiller's Duquesne adds Microsoft, IQVIA, exits Cenovus Energy, Lennar",Seeking Alpha,https://seekingalpha.com/news/3971810-druckenmillers-duquesne-adds-microsoft-iqvia-exits-cenovus-energy-lennar?utm_source=businessinsider&utm_medium=referral,positive,0.9470711350440979
221,5/18/2023 2:56:47 PM,IQVIA To Raise $1 Bln Through Notes Offering ,RTTNews,/news/stocks/iqvia-to-raise-1-bln-through-notes-offering-1032337494,positive,0.6460950970649719
222,5/25/2023 9:47:53 AM,"Abbott, IQVIA, Global Fund, partners commit $54M to boost laboratory system for pandemics",Seeking Alpha,https://seekingalpha.com/news/3974944-abbott-iqvia-global-fund-partners-commit-54m-to-boost-laboratory-system-for-pandemics?utm_source=businessinsider&utm_medium=referral,negative,0.8393557071685791
223,6/27/2023 9:25:05 AM,Barclays Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-iqvia-holdings-iqv-1032411624,positive,0.9224793314933777
224,7/2/2023 4:00:52 PM,What’s next for clinical research firms after pandemic boom?,Seeking Alpha,https://seekingalpha.com/news/3984828-future-contract-services-organizations-after-covid-boom?utm_source=businessinsider&utm_medium=referral,positive,0.9223032593727112
225,7/17/2023 4:22:46 PM,FTC sues to challenge IQVIA's planned acquisition of Propel Media,Seeking Alpha,https://seekingalpha.com/news/3988102-ftc-sues-to-challenge-iqvias-planned-acquisition-of-propel-media?utm_source=businessinsider&utm_medium=referral,neutral,0.8409178256988525
226,7/18/2023 10:00:51 PM,What 7 Analyst Ratings Have To Say About IQVIA Hldgs,Benzinga,/news/stocks/what-7-analyst-ratings-have-to-say-about-iqvia-hldgs-1032456163,positive,0.9443796277046204
227,7/31/2023 2:46:05 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3993451-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
228,7/31/2023 3:01:13 PM,IQVIA earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-stock-price-q2-earnings-preview-1032495422,positive,0.9325198531150818
229,7/31/2023 6:34:07 PM,IQVIA Q2 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3993617-iqvia-q2-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8765063881874084
230,8/1/2023 11:09:34 AM,"IQVIA Non-GAAP EPS of $2.43 beats by $0.06, revenue of $3.73B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/3994038-iqvia-non-gaap-eps-of-2_43-beats-0_06-revenue-of-3_73b-beats-20m?utm_source=businessinsider&utm_medium=referral,positive,0.7342718243598938
231,8/1/2023 1:16:11 PM,"IQVIA Holdings Inc. Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q2-profit-increases-beats-estimates-1032500141,negative,0.9397760033607483
232,8/2/2023 9:32:46 AM,"Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Vertex Pharmaceuticals (VRTX) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-idexx-laboratories-idxx-vertex-pharmaceuticals-vrtx-and-iqvia-holdings-iqv-1032505747,positive,0.9153348207473755
233,8/2/2023 10:07:21 AM,"Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-encompass-health-ehc-iqvia-holdings-iqv-1032505890,positive,0.5100895166397095
234,8/2/2023 2:40:31 PM,"Analysts’ Top Healthcare Picks: Exact Sciences (EXAS), IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-top-healthcare-picks-exact-sciences-exas-iqvia-holdings-iqv-1032507641,negative,0.6541487574577332
235,8/3/2023 2:30:40 AM,"Analysts’ Top Healthcare Picks: Tenet Healthcare (THC), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-tenet-healthcare-thc-vertex-pharmaceuticals-vrtx-1032509298,negative,0.7912315726280212
236,8/4/2023 7:50:21 AM,Analysts Offer Insights on Healthcare Companies: Nevro Corp (NVRO) and IQVIA Holdings (IQV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-nevro-corp-nvro-and-iqvia-holdings-iqv-1032516705,positive,0.9305542707443237
237,8/14/2023 8:21:26 PM,"Stan Druckenmiller's Duquesne adds GE, Builders FirstSource, exits AMD",Seeking Alpha,https://seekingalpha.com/news/4002535-stan-druckenmmillers-duquesne-adds-ge-builders-firstsource-exits-amd?utm_source=businessinsider&utm_medium=referral,positive,0.9257884621620178
238,8/22/2023 6:03:33 PM,Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor,Benzinga,/news/stocks/goldman-sachs-reveals-long-term-ai-portfolio-here-are-the-50-stocks-to-monitor-1032573922,positive,0.9433931112289429
239,8/28/2023 10:48:26 AM,Elite says generic is comparable to branded CNS stimulant,Seeking Alpha,https://seekingalpha.com/news/4006652-elite-generic-comparable-branded-cns-stimulant?utm_source=businessinsider&utm_medium=referral,negative,0.6254677176475525
240,8/30/2023 12:54:37 PM,3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of,InvestorPlace,/news/stocks/3-biotech-stocks-that-wall-street-analysts-cant-get-enough-of-1032592710,positive,0.6408605575561523
241,9/6/2023 5:00:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-6-2023-1032609929,positive,0.5207832455635071
242,9/10/2023 7:17:31 PM,"HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead",Seeking Alpha,https://seekingalpha.com/news/4010430-hsbc-bullish-on-iqvia-zoetis-bluebird-actinium-bearish-on-gilead?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5512140393257141
243,9/12/2023 12:17:06 PM,ANI Pharma wins FDA nod for generic Estradiol tablets,Seeking Alpha,https://seekingalpha.com/news/4010917-ani-pharma-stock-gains-fda-nod-generic-estradiol-tablets?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9334229826927185
244,9/29/2023 2:00:41 PM,Analyst Expectations for IQVIA Hldgs's Future,Benzinga,/news/stocks/analyst-expectations-for-iqvia-hldgs-s-future-1032666195,negative,0.8362643122673035
245,10/4/2023 2:30:22 AM,Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-and-pfizer-pfe-1032676108,positive,0.9164672493934631
246,10/17/2023 2:00:51 PM,The Latest Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/the-latest-analyst-ratings-for-iqvia-hldgs-1032712148,positive,0.935731053352356
247,10/25/2023 2:30:13 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Danaher (DHR) and Aura Biosciences Inc (AURA)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-iqvia-holdings-iqv-danaher-dhr-and-aura-biosciences-inc-aura-1032739553,neutral,0.6170918941497803
248,10/31/2023 3:01:13 PM,Here's what to expect from IQVIA's earnings report,Markets Insider Automation,/news/stocks/iqvia-stock-q3-earnings-preview-1032759657,positive,0.9314884543418884
249,11/1/2023 12:19:26 PM,"IQVIA Holdings Inc. Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q3-profit-increases-beats-estimates-1032764523,negative,0.9386873841285706
250,11/1/2023 1:04:10 PM,IQVIA Holdings Slashes FY23 Outlook - Update ,RTTNews,/news/stocks/iqvia-holdings-slashes-fy23-outlook-update-1032764734,neutral,0.93416827917099
251,11/2/2023 8:26:38 AM,"Hold Rating for IQVIA Holdings: Assessing Growth Prospects, Risks and Debates Amidst Strong RDS Core and Investor Concerns",TipRanks,/news/stocks/hold-rating-for-iqvia-holdings-assessing-growth-prospects-risks-and-debates-amidst-strong-rds-core-and-investor-concerns-1032772227,positive,0.8461462259292603
252,11/2/2023 6:25:19 PM,Buy Rating Reaffirmed for IQVIA Holdings Despite Lowered FY23 Guide: A Look at Long-Term Growth Potential and Differentiated Portfolio,TipRanks,/news/stocks/buy-rating-reaffirmed-for-iqvia-holdings-despite-lowered-fy23-guide-a-look-at-long-term-growth-potential-and-differentiated-portfolio-1032774900,positive,0.6344740390777588
253,11/2/2023 7:28:01 PM,Resilient Demand and Undemanding Valuation: A Buy Rating for IQVIA Holdings Despite Challenges,TipRanks,/news/stocks/resilient-demand-and-undemanding-valuation-a-buy-rating-for-iqvia-holdings-despite-challenges-1032775136,negative,0.8896912932395935
254,11/3/2023 1:25:26 AM,Barclays Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-remains-a-buy-on-iqvia-holdings-iqv-1032776257,positive,0.9434985518455505
255,11/3/2023 2:10:06 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Idexx Laboratories (IDXX) and Argenx Se (ARGX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-iqvia-holdings-iqv-idexx-laboratories-idxx-and-argenx-se-argx-1032776401,neutral,0.7314620614051819
256,11/3/2023 2:30:51 AM,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), IQVIA Holdings (IQV) and Argenx Se (ARGX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-amgen-amgn-iqvia-holdings-iqv-and-argenx-se-argx-1032776513,positive,0.9180508852005005
257,11/3/2023 1:00:51 PM,The Latest Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/the-latest-analyst-ratings-for-iqvia-hldgs-1032775996,positive,0.935731053352356
258,11/6/2023 6:40:15 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Seagen (SGEN), IQVIA Holdings (IQV) and C4 Therapeutics (CCCC)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-seagen-sgen-iqvia-holdings-iqv-and-c4-therapeutics-cccc-1032783451,neutral,0.9225879907608032
259,11/21/2023 9:00:26 PM,Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/analyst-ratings-for-iqvia-hldgs-1032840617,positive,0.913325309753418
260,11/23/2023 2:30:14 AM,"Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Biogen (BIIB)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-iqvia-holdings-iqv-biogen-biib-1032845842,positive,0.6621273756027222
261,12/1/2023 1:30:47 PM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-progyny-pgny-and-iqvia-holdings-iqv-1032867916,positive,0.9191668629646301
262,12/11/2023 2:00:58 PM,The Latest Analyst Ratings for IQVIA Hldgs,Benzinga,/news/stocks/the-latest-analyst-ratings-for-iqvia-hldgs-1032889338,positive,0.935731053352356
263,1/4/2024 8:00:27 PM,IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings),Benzinga,/news/stocks/iqvia-hldgs-stock-a-deep-dive-into-analyst-perspectives-11-ratings-1032944270,positive,0.8597895503044128
264,1/9/2024 5:02:00 PM,The 7 Best Growth Stocks to Buy Now,InvestorPlace,/news/stocks/best-growth-stocks-1031565902,positive,0.8464112877845764
265,1/10/2024 11:16:41 PM,"If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-biotech-stock-in-january-it-better-be-one-of-these-3-names-1032958708,positive,0.9418983459472656
266,1/24/2024 1:54:54 PM,Biogen slips as UBS cuts to Neutral on Alzheimer’s drug uptake,Seeking Alpha,https://seekingalpha.com/news/4057849-biogen-stock-slips-ubs-downgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.89500892162323
267,1/25/2024 4:00:44 PM,Expert Ratings For IQVIA Hldgs,Benzinga,/news/stocks/expert-ratings-for-iqvia-hldgs-1032997475,positive,0.8439691662788391
268,2/13/2024 2:00:25 PM,Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights,Benzinga,/news/stocks/peeling-back-the-layers-exploring-iqvia-hldgs-through-analyst-insights-1033060697,positive,0.882924497127533
269,2/13/2024 3:01:13 PM,IQVIA earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/iqvia-stock-price-q4-earnings-preview-1033061220,positive,0.9205178022384644
270,2/13/2024 3:25:27 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4066102-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.855887770652771
271,2/13/2024 4:08:43 PM,IQVIA Q4 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4066142-iqvia-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8775954842567444
272,2/14/2024 12:06:21 PM,IQVIA beats top-line and bottom-line estimates; initiates FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4066619-iqvia-beats-top-line-and-bottom-line-estimates-initiates-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5409829616546631
273,2/14/2024 1:10:12 PM,"IQVIA Holdings Inc. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/iqvia-holdings-inc-q4-profit-increases-beats-estimates-1033066101,negative,0.9396405220031738
274,2/14/2024 1:33:54 PM,IQVIA Holdings Guides FY24 In Line With Estimates - Update ,RTTNews,/news/stocks/iqvia-holdings-guides-fy24-in-line-with-estimates-update-1033066157,positive,0.8142111897468567
275,2/14/2024 4:06:30 PM,IQVIA Reaches New High After Upbeat Quarterly Results ,RTTNews,/news/stocks/iqvia-reaches-new-high-after-upbeat-quarterly-results-1033067267,negative,0.8874990344047546
276,2/14/2024 4:36:39 PM,"Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday",Benzinga,/news/stocks/charles-river-laboratories-international-posts-upbeat-results-joins-robinhood-zillow-tower-semiconductor-and-other-big-stocks-moving-higher-on-wednesday-1033067412,negative,0.9394280910491943
277,2/14/2024 7:11:46 PM,Contract research firms gain after Q4 results,Seeking Alpha,https://seekingalpha.com/news/4067009-contract-research-firms-gains-after-q4-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8656876087188721
278,2/14/2024 7:51:53 PM,"Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?",Benzinga,/news/stocks/stocks-rebound-as-investor-focus-shifts-to-earnings-bitcoin-tops-1-trillion-value-what-s-driving-markets-wednesday-1033067964,positive,0.5915220975875854
279,2/15/2024 8:10:46 AM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Evolent Health (EVH) and InMode (INMD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-evolent-health-evh-and-inmode-inmd-1033070919,positive,0.9163623452186584
280,2/15/2024 11:17:46 AM,IQVIA Holdings: A Strong Buy on Robust TAS Growth and RDS Stability,TipRanks,/news/stocks/iqvia-holdings-a-strong-buy-on-robust-tas-growth-and-rds-stability-1033071931,negative,0.9532933831214905
281,2/15/2024 11:20:55 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033071925,negative,0.5521676540374756
282,2/26/2024 12:20:30 PM,"Analysts Are Bullish on Top Healthcare Stocks: BeiGene (BGNE), McKesson (MCK)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-beigene-bgne-mckesson-mck-1033103380,positive,0.5832799673080444
283,2/27/2024 12:41:42 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Staar Surgical (STAA), IQVIA Holdings (IQV) and Bausch Health Companies (BHC)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-staar-surgical-staa-iqvia-holdings-iqv-and-bausch-health-companies-bhc-1033108378,neutral,0.7183254957199097
284,3/6/2024 1:06:12 PM,Truist Financial Sticks to Their Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/truist-financial-sticks-to-their-buy-rating-for-iqvia-holdings-iqv-1033138593,positive,0.7674773335456848
285,3/15/2024 7:38:23 PM,Eli Lilly Zepbound prescriptions exceed Novo’s Wegovy for the first time in U.S.,Seeking Alpha,https://seekingalpha.com/news/4080150-eli-lilly-zepbound-prescriptions-exceed-novos-wegovy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9436370730400085
286,3/16/2024 4:57:30 PM,NASH drug market expected to surpass $48B by 2035,Seeking Alpha,https://seekingalpha.com/news/4080234-nash-drug-market-expected-top-48b-2035?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8953897953033447
287,3/29/2024 7:20:42 AM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), United Therapeutics (UTHR) and Immunome (IMNM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-united-therapeutics-uthr-and-immunome-imnm-1033208058,positive,0.9222140908241272
288,4/5/2024 12:30:53 PM,AbbVie’s Humira outperforms forcing biosimilar maker to cut sales staff,Seeking Alpha,https://seekingalpha.com/news/4087542-abbvies-humira-outperforms-boehringer-ingelheim-cuts-staff?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9702324867248535
289,4/9/2024 11:35:55 AM,Truist Financial Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/truist-financial-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1033234036,positive,0.8210132718086243
290,4/10/2024 6:47:18 AM,IQVIA Holdings (IQV) Gets a Buy from Barclays,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-barclays-1033236395,positive,0.8026481866836548
291,4/10/2024 5:49:47 PM,Global Stock leaders for 2030 in Health Tech - UBS,Seeking Alpha,https://seekingalpha.com/news/4088685-global-stock-leaders-for-2030-in-health-tech-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6284363865852356
292,4/13/2024 2:52:04 PM,AbbVie keeps Humira market share near 100% despite biosimilars: report,Seeking Alpha,https://seekingalpha.com/news/4089412-abbvie-retains-humira-market-despite-copycats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5874672532081604
293,4/17/2024 2:35:30 PM,Bank of America Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1033259193,positive,0.8750925064086914
294,4/23/2024 4:57:53 PM,Medpace raised to Buy at Jefferies after Q1 earnings beat,Seeking Alpha,https://seekingalpha.com/news/4092679-medpase-stock-upgraded-buy-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8097056746482849
295,5/1/2024 3:01:13 PM,IQVIA earnings: here's what to expect,Markets Insider Automation,/news/stocks/iqvia-q1-earnings-preview-stock-1033313199,positive,0.9376915097236633
296,5/1/2024 3:22:41 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/4097413-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8825733065605164
297,5/1/2024 3:30:26 PM,IQVIA Q1 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4097431-iqvia-q1-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8759979605674744
298,5/1/2024 8:30:00 PM,Analysts Are Pounding the Table on These 3 Stocks: April 2024,InvestorPlace,/news/stocks/analysts-are-pounding-the-table-on-these-3-stocks-april-2024-1033315515,positive,0.9128440022468567
299,5/2/2024 11:05:23 AM,"IQVIA Non-GAAP EPS of $2.54 beats by $0.06, revenue of $3.74B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4098318-iqvia-non-gaap-eps-of-2_54-beats-0_06-revenue-of-3_74b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7436116933822632
300,5/2/2024 1:15:17 PM,IQVIA Holdings Inc. Q1 Profit Beats Estimates,RTTNews,/news/stocks/iqvia-holdings-inc-q1-profit-beats-estimates-1033319078,negative,0.6775571703910828
301,5/2/2024 3:55:59 PM,"IQV Stock Earnings: IQVIA Hldgs Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/iqv-stock-earnings-iqvia-hldgs-for-q1-of-2024-1033321506,negative,0.7222532033920288
302,5/3/2024 11:45:18 AM,IQVIA Holdings (IQV) Receives a Buy from Truist Financial,TipRanks,/news/stocks/iqvia-holdings-iqv-receives-a-buy-from-truist-financial-1033327457,positive,0.8072782754898071
303,5/3/2024 12:16:10 PM,Buy Rating Affirmed for IQVIA Holdings Amidst Strong Growth and Resilient Demand,TipRanks,/news/stocks/buy-rating-affirmed-for-iqvia-holdings-amidst-strong-growth-and-resilient-demand-1033327629,negative,0.9515286684036255
304,5/3/2024 3:01:36 PM,Forecasting The Future: 8 Analyst Projections For IQVIA Hldgs,Benzinga,/news/stocks/forecasting-the-future-8-analyst-projections-for-iqvia-hldgs-1033326416,positive,0.93459552526474
305,5/3/2024 3:28:05 PM,IQVIA Holdings (IQV) Gets a Buy from Bank of America Securities,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-bank-of-america-securities-1033328161,positive,0.7517449855804443
306,5/9/2024 2:08:28 AM,Stifel Nicolaus Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/stifel-nicolaus-keeps-their-buy-rating-on-iqvia-holdings-iqv-1033354188,positive,0.9208752512931824
307,5/9/2024 2:30:29 AM,"Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-iqvia-holdings-iqv-cvs-health-cvs-1033354281,positive,0.8112159371376038
308,5/28/2024 12:05:31 PM,IQVIA Holdings (IQV) Gets a Buy from Jefferies,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-jefferies-1033427781,positive,0.8651090860366821
309,6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9165980219841003
310,6/6/2024 4:00:29 PM,Analyst Scoreboard: 4 Ratings For IQVIA Hldgs,Benzinga,/news/stocks/analyst-scoreboard-4-ratings-for-iqvia-hldgs-1033458057,positive,0.8976162672042847
311,6/18/2024 9:49:21 AM,"‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider",TipRanks,/news/stocks/the-cro-sector-looks-appealing-says-goldman-sachs-—-here-are-2-stocks-to-consider-1033486976,positive,0.8828693628311157
312,6/28/2024 9:31:43 AM,Barclays Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-keeps-their-buy-rating-on-iqvia-holdings-iqv-1033514877,positive,0.9224793314933777
313,6/28/2024 10:00:17 PM,5 Analysts Assess IQVIA Hldgs: What You Need To Know,Benzinga,/news/stocks/5-analysts-assess-iqvia-hldgs-what-you-need-to-know-1033516503,positive,0.927156925201416
314,7/19/2024 1:16:25 PM,Notable earnings before Monday's open,Seeking Alpha,https://seekingalpha.com/news/4125841-notable-earnings-before-mondays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8824691772460938
315,7/19/2024 4:08:11 PM,IQVIA Q2 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4125899-iqvia-q2-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8792352080345154
316,7/21/2024 3:01:13 PM,IQVIA earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/iqvia-quarter-earnings-preview-q2-1033574379,positive,0.9325198531150818
317,7/22/2024 11:03:24 AM,"IQVIA Non-GAAP EPS of $2.64 beats by $0.08, revenue of $3.81B beats by $20M",Seeking Alpha,https://seekingalpha.com/news/4126128-iqvia-non-gaap-eps-of-2_64-beats-0_08-revenue-of-3_81b-beats-20m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7183021903038025
318,7/22/2024 11:16:03 AM,"Earnings Summary: IQVIA Holdings tops Q2 consensus, updates FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4126140-earnings-summary-iqvia-holdings-tops-q2-consensus-updates-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7976141571998596
319,7/22/2024 1:05:59 PM,"IQVIA Holdings Inc. Q2 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/iqvia-holdings-inc-q2-profit-increases-beats-estimates-1033577181,negative,0.9397760033607483
320,7/22/2024 1:38:52 PM,"IQVIA Lifts FY24 Earnings, Revenue View Above Market; Stock Up In Pre-market ",RTTNews,/news/stocks/iqvia-lifts-fy24-earnings-revenue-view-above-market-stock-up-in-pre-market-1033577249,negative,0.9480507373809814
321,7/22/2024 1:55:28 PM,"Biggest stock movers today: VZ, RYAAY, CRWD, NVDA, and more",Seeking Alpha,https://seekingalpha.com/news/4126079-biggest-stock-movers-today-ryaay-crwd-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9094010591506958
322,7/22/2024 4:25:08 PM,"IQVIA up 6% following FY 2024 guidance update, quarterly beats",Seeking Alpha,https://seekingalpha.com/news/4126348-iqvia-up-6-following-fy-2024-guidance-update-quarterly-beats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9551610946655273
323,7/22/2024 4:37:45 PM,"IQVIA 'Is A Solid Investment' With Strong Competitive Positioning, Analyst Says After Better Than Expected Q2 Earnings",Benzinga,/news/stocks/iqvia-is-a-solid-investment-with-strong-competitive-positioning-analyst-says-after-better-than-expected-q2-earnings-1033578454,negative,0.9532364010810852
324,7/22/2024 7:36:59 PM,"US Stocks Rebound As Tech Surges, CrowdStrike Continues Selloff, Oil Hits 1-Month Lows: What's Driving Markets Monday?",Benzinga,/news/etf/us-stocks-rebound-as-tech-surges-crowdstrike-continues-selloff-oil-hits-1-month-lows-what-s-driving-markets-monday-1033579047,neutral,0.8494281768798828
325,7/23/2024 12:35:39 AM,"IQVIA Holdings: Strong H2 Outlook with Buoyant TAS, RWE, and RDS Segments Driving Buy Rating",TipRanks,/news/stocks/iqvia-holdings-strong-h2-outlook-with-buoyant-tas-rwe-and-rds-segments-driving-buy-rating-1033579663,negative,0.9471269845962524
326,7/23/2024 7:27:53 AM,Barclays Sticks to Its Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-sticks-to-its-buy-rating-for-iqvia-holdings-iqv-1033581813,positive,0.8504310250282288
327,7/23/2024 9:01:08 AM,IQVIA Holdings: Strong Q2 Performance and Raised Annual Guidance Prompt ‘Buy’ Rating,TipRanks,/news/stocks/iqvia-holdings-strong-q2-performance-and-raised-annual-guidance-prompt-buy-rating-1033582183,negative,0.9530000686645508
328,7/23/2024 9:01:21 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-iqvia-holdings-iqv-vertex-pharmaceuticals-vrtx-and-gilead-sciences-gild-1033582182,neutral,0.7335153222084045
329,7/23/2024 10:19:15 AM,IQVIA Holdings: Robust Financial Performance and Positive Outlook Reinforce Buy Rating,TipRanks,/news/stocks/iqvia-holdings-robust-financial-performance-and-positive-outlook-reinforce-buy-rating-1033582697,negative,0.942500114440918
330,7/23/2024 11:15:19 AM,Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/truist-financial-sticks-to-its-buy-rating-for-iqvia-holdings-iqv-1033583250,negative,0.6105898022651672
331,7/23/2024 11:57:25 AM,Evercore ISI Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/evercore-isi-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1033583342,positive,0.8873817920684814
332,7/23/2024 3:51:30 PM,These Analysts Boost Their Forecasts On IQVIA After Better-Than-Expected Earnings,Benzinga,/news/stocks/these-analysts-boost-their-forecasts-on-iqvia-after-better-than-expected-earnings-1033582828,negative,0.9416992664337158
333,7/23/2024 9:01:28 PM,IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (13 Ratings),Benzinga,/news/stocks/iqvia-hldgs-stock-a-deep-dive-into-analyst-perspectives-13-ratings-1033584215,positive,0.8617416024208069
334,7/24/2024 5:55:32 AM,IQVIA Holdings Outperforms with Strong Q2 Results and Positive Growth Outlook: Cherny Maintains Buy Rating,TipRanks,/news/stocks/iqvia-holdings-outperforms-with-strong-q2-results-and-positive-growth-outlook-cherny-maintains-buy-rating-1033587340,negative,0.9253357648849487
335,7/24/2024 8:17:58 AM,IQVIA Holdings: A Buy Rating Backed by Strong Financials and Positive Market Outlook,TipRanks,/news/stocks/iqvia-holdings-a-buy-rating-backed-by-strong-financials-and-positive-market-outlook-1033588011,negative,0.9026553630828857
336,7/24/2024 8:36:15 AM,IQVIA Holdings: A Strong Buy on Robust R&D and Tech Growth Prospects,TipRanks,/news/stocks/iqvia-holdings-a-strong-buy-on-robust-r-d-and-tech-growth-prospects-1033588100,negative,0.9536013603210449
337,7/24/2024 12:27:43 PM,Jefferies Sticks to Their Hold Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/jefferies-sticks-to-their-hold-rating-for-iqvia-holdings-iqv-1033589887,positive,0.9015956521034241
338,7/24/2024 7:22:19 PM,"Jefferies downgrades IQVIA to hold, cites subdued market outlook",Seeking Alpha,https://seekingalpha.com/news/4127813-jefferies-downgrades-iqvia-to-hold-cites-subdued-market-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9356850385665894
339,7/25/2024 2:05:08 AM,Stifel Nicolaus Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/stifel-nicolaus-remains-a-buy-on-iqvia-holdings-iqv-1033592451,positive,0.9504736661911011
340,7/31/2024 3:16:32 PM,IQVIA Holdings (IQV) Receives a Buy from Argus Research,TipRanks,/news/stocks/iqvia-holdings-iqv-receives-a-buy-from-argus-research-1033620406,positive,0.8545212745666504
341,9/5/2024 11:20:06 AM,Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and BioMarin Pharmaceutical (BMRN),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-and-biomarin-pharmaceutical-bmrn-1033751300,positive,0.9008080959320068
342,9/11/2024 3:15:15 PM,Supernus cut to Neutral at Piper Sandler on Qelbree growth trajectory,Seeking Alpha,https://seekingalpha.com/news/4148713-supernus-stock-cut-neutral-at-piper-sandler?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6251972317695618
343,9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9156707525253296
344,9/18/2024 7:28:20 PM,ICON draws bullish view at Leerink on business model,Seeking Alpha,https://seekingalpha.com/news/4150885-icon-stock-draws-bullish-view-leerink?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.723064661026001
345,9/24/2024 11:26:04 AM,Truist Financial Gives a Buy Rating to IQVIA Holdings (IQV),TipRanks,/news/stocks/truist-financial-gives-a-buy-rating-to-iqvia-holdings-iqv-1033794307,positive,0.8798540830612183
346,9/25/2024 1:01:41 PM,"Medpace, Fortrea cut as Jefferies reviews CROs amid biotech headwinds",Seeking Alpha,https://seekingalpha.com/news/4153080-medpace-stock-fortrea-stock-cut-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9320017695426941
347,10/1/2024 1:29:59 PM,Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR,Seeking Alpha,https://seekingalpha.com/news/4155002-teva-launches-first-sandostatin-lar-generic?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.549048900604248
348,10/7/2024 11:50:08 AM,Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and Acumen Pharmaceuticals (ABOS),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-and-acumen-pharmaceuticals-abos-1033825319,positive,0.9115190505981445
349,10/23/2024 11:21:11 AM,Iqvia price target lowered to $279 from $288 at JPMorgan,TipRanks,/news/stocks/iqvia-price-target-lowered-to-279-from-288-at-jpmorgan-1033879307,neutral,0.8607538342475891
350,10/24/2024 6:32:38 PM,ICON leads a selloff among CROs after guidance cut; Baird downgrades,Seeking Alpha,https://seekingalpha.com/news/4201626-icon-stock-slips-after-guidance-cut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9538301229476929
351,10/28/2024 8:51:14 AM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Eli Lilly & Co (LLY) and Ligand Pharma (LGND)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-eli-lilly-co-lly-and-ligand-pharma-lgnd-1033901057,positive,0.9199034571647644
352,10/28/2024 12:15:37 PM,GoodRx appoints Iqvia CFO Ronald Bruehlman to board,TipRanks,/news/stocks/goodrx-appoints-iqvia-cfo-ronald-bruehlman-to-board-1033902738,positive,0.9287685751914978
353,10/29/2024 10:26:36 AM,RBC Capital Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-iqvia-holdings-iqv-1033909108,positive,0.9269649386405945
354,10/29/2024 12:55:31 PM,Iqvia price target lowered to $270 from $275 at RBC Capital,TipRanks,/news/stocks/iqvia-price-target-lowered-to-270-from-275-at-rbc-capital-1033910636,neutral,0.7469615340232849
355,10/30/2024 12:35:55 PM,IQVIA Holdings’ Acquisition Strategy: Limited Revenue Growth and Market Challenges Justify Hold Rating,TipRanks,/news/stocks/iqvia-holdings-acquisition-strategy-limited-revenue-growth-and-market-challenges-justify-hold-rating-1033919303,positive,0.498538076877594
356,10/30/2024 3:17:38 PM,IQVIA Q3 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4223999-iqvia-q3-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8682233095169067
357,10/30/2024 10:00:58 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4223412-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9330109357833862
358,10/31/2024 11:16:21 AM,"IQVIA Non-GAAP EPS of $2.84 beats by $0.03, revenue of $3.89B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/4227914-iqvia-non-gaap-eps-of-2_84-beats-0_03-revenue-of-3_89b-beats-30m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7787079215049744
359,10/31/2024 12:22:40 PM,"IQVIA Holdings Inc. Q3 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/iqvia-holdings-inc-q3-profit-decreases-but-beats-estimates-1033927049,neutral,0.9641834497451782
360,11/1/2024 3:55:22 AM,IQVIA Holdings: Buy Rating Driven by Strategic Partnerships and Growth Prospects,TipRanks,/news/stocks/iqvia-holdings-buy-rating-driven-by-strategic-partnerships-and-growth-prospects-1033934238,negative,0.5084526538848877
361,11/1/2024 4:00:44 AM,IQVIA Holdings Sees Strong Q3 Growth Amid Challenges,TipRanks,/news/stocks/iqvia-holdings-sees-strong-q3-growth-amid-challenges-1033934339,negative,0.9531480073928833
362,11/1/2024 7:20:14 AM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Alphatec Holdings (ATEC) and Alnylam Pharma (ALNY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-alphatec-holdings-atec-and-alnylam-pharma-alny-1033935536,positive,0.9201890230178833
363,11/1/2024 9:09:17 AM,Resilient Performance and Strategic Growth Drive IQVIA Holdings Buy Rating,TipRanks,/news/stocks/resilient-performance-and-strategic-growth-drive-iqvia-holdings-buy-rating-1033936022,negative,0.9088819622993469
364,11/1/2024 9:45:27 AM,Iqvia price target lowered to $255 from $260 at Barclays,TipRanks,/news/stocks/iqvia-price-target-lowered-to-255-from-260-at-barclays-1033936368,neutral,0.8097817301750183
365,11/1/2024 9:59:52 AM,Strong TAS Performance and Strategic Measures Uphold IQVIA’s Buy Rating Despite CRO Challenges,TipRanks,/news/stocks/strong-tas-performance-and-strategic-measures-uphold-iqvia-s-buy-rating-despite-cro-challenges-1033936529,negative,0.9559098482131958
366,11/1/2024 10:51:11 AM,Iqvia price target lowered to $223 from $256 at Baird,TipRanks,/news/stocks/iqvia-price-target-lowered-to-223-from-256-at-baird-1033936805,neutral,0.6763068437576294
367,11/1/2024 11:26:05 AM,Iqvia price target lowered to $260 from $290 at BTIG,TipRanks,/news/stocks/iqvia-price-target-lowered-to-260-from-290-at-btig-1033936986,neutral,0.596790611743927
368,11/1/2024 11:51:49 AM,Iqvia price target lowered to $255 from $270 at TD Cowen,TipRanks,/news/stocks/iqvia-price-target-lowered-to-255-from-270-at-td-cowen-1033937203,neutral,0.6222848296165466
369,11/1/2024 12:45:27 PM,Iqvia price target lowered to $265 from $270 at Deutsche Bank,TipRanks,/news/stocks/iqvia-price-target-lowered-to-265-from-270-at-deutsche-bank-1033937978,neutral,0.8187408447265625
370,11/4/2024 11:39:02 AM,Resilient Performance and Strategic Opportunities Drive Buy Rating for IQVIA Holdings,TipRanks,/news/stocks/resilient-performance-and-strategic-opportunities-drive-buy-rating-for-iqvia-holdings-1033944353,negative,0.868473470211029
371,11/4/2024 12:11:10 PM,Iqvia price target lowered to $265 from $280 at Morgan Stanley,TipRanks,/news/stocks/iqvia-price-target-lowered-to-265-from-280-at-morgan-stanley-1033944884,neutral,0.8242558240890503
372,11/5/2024 2:09:55 AM,Stifel Nicolaus Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/stifel-nicolaus-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1033948053,positive,0.8671395182609558
373,11/5/2024 5:40:20 AM,"Analysts Conflicted on These Healthcare Names: IQVIA Holdings (IQV), Halozyme (HALO) and Kymera Therapeutics (KYMR)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-iqvia-holdings-iqv-halozyme-halo-and-kymera-therapeutics-kymr-1033949961,neutral,0.781079888343811
374,11/5/2024 10:26:47 AM,BTIG Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/btig-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1033951543,positive,0.8357468247413635
375,11/5/2024 12:11:44 PM,"Analysts Offer Insights on Healthcare Companies: Glaukos (GKOS), Regeneron (REGN) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-glaukos-gkos-regeneron-regn-and-iqvia-holdings-iqv-1033952722,positive,0.916696310043335
376,11/5/2024 12:20:18 PM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Kobayashi Pharmaceutical Co (OtherKBYPF) and Irhythm Technologies (IRTC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-kobayashi-pharmaceutical-co-otherkbypf-and-irhythm-technologies-irtc-1033952929,positive,0.9150891900062561
377,11/5/2024 8:44:22 PM,AstraZeneca’s China business under spotlight amid fraud case,Seeking Alpha,https://seekingalpha.com/news/4251540-astra-zeneca-china-unit-spotlight-amid-fraud-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9158048033714294
378,11/6/2024 2:30:38 PM,Iqvia price target lowered to $260 from $280 at Argus,TipRanks,/news/stocks/iqvia-price-target-lowered-to-260-from-280-at-argus-1033963442,neutral,0.7549991011619568
379,11/27/2024 11:23:42 AM,Trump taps Jay Bhattacharya to lead National Institutes of Health,Seeking Alpha,https://seekingalpha.com/news/4338432-trump-taps-jay-bhattacharya-to-lead-national-institutes-of-health?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8861560225486755
380,12/5/2024 4:42:03 PM,RBC Capital Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/rbc-capital-remains-a-buy-on-iqvia-holdings-iqv-1034104083,positive,0.9495704770088196
381,12/5/2024 5:50:15 PM,"Analysts Offer Insights on Healthcare Companies: Merus (MRUS), IQVIA Holdings (IQV) and Harmony Biosciences Holdings (HRMY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-merus-mrus-iqvia-holdings-iqv-and-harmony-biosciences-holdings-hrmy-1034104666,positive,0.9183248281478882
382,12/6/2024 1:01:15 PM,"Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Novavax (NVAX) and Veeva Systems (VEEV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-novavax-nvax-and-veeva-systems-veev-1034108886,positive,0.9198234677314758
383,12/6/2024 8:00:00 PM,"Catalyst Watch:  Goldman Sachs finance conference; Adobe, CostCo earnings",Seeking Alpha,https://seekingalpha.com/news/4364004-catalyst-watch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9471288919448853
384,12/11/2024 9:25:57 AM,IQVIA Holdings (IQV) Gets a Buy from Barclays,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-barclays-1034123715,positive,0.8026481866836548
385,12/11/2024 10:36:31 AM,IQVIA Holdings: Strategic AI Integration and Realistic Growth Outlook Justify Buy Rating,TipRanks,/news/stocks/iqvia-holdings-strategic-ai-integration-and-realistic-growth-outlook-justify-buy-rating-1034124199,positive,0.6388089656829834
386,12/11/2024 10:56:47 AM,IQVIA Holdings: Moderate Growth Projections and Neutral Rating Amid Market Expectations,TipRanks,/news/stocks/iqvia-holdings-moderate-growth-projections-and-neutral-rating-amid-market-expectations-1034124256,neutral,0.9029725790023804
387,12/11/2024 11:37:51 AM,TD Cowen Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/td-cowen-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1034124659,positive,0.8582381010055542
388,12/11/2024 11:39:18 AM,IQVIA Holdings (IQV) Gets a Buy from RBC Capital,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-rbc-capital-1034124634,positive,0.8630354404449463
389,12/11/2024 12:01:16 PM,Iqvia price target lowered to $212 from $213 at Baird,TipRanks,/news/stocks/iqvia-price-target-lowered-to-212-from-213-at-baird-1034125234,neutral,0.7727323770523071
390,12/11/2024 12:45:33 PM,IQVIA Holdings (IQV) Receives a Buy from Stifel Nicolaus,TipRanks,/news/stocks/iqvia-holdings-iqv-receives-a-buy-from-stifel-nicolaus-1034125543,positive,0.8099274635314941
391,12/11/2024 1:16:13 PM,IQVIA Holdings (IQV) Receives a Buy from Evercore ISI,TipRanks,/news/stocks/iqvia-holdings-iqv-receives-a-buy-from-evercore-isi-1034125737,positive,0.7428321242332458
392,12/12/2024 7:16:02 AM,IQVIA Holdings: Promising Growth Trajectory and Strategic AI Integration Support Buy Rating,TipRanks,/news/stocks/iqvia-holdings-promising-growth-trajectory-and-strategic-ai-integration-support-buy-rating-1034128701,negative,0.9211457371711731
393,12/12/2024 12:25:30 PM,IQVIA Holdings (IQV) Gets a Buy from Truist Financial,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-truist-financial-1034130679,positive,0.8469009399414062
394,12/12/2024 2:40:47 PM,Iqvia price target lowered to $261 from $265 at Truist,TipRanks,/news/stocks/iqvia-price-target-lowered-to-261-from-265-at-truist-1034131521,neutral,0.6352850198745728
395,12/13/2024 1:15:19 PM,Iqvia price target lowered to $235 from $255 at BofA,TipRanks,/news/stocks/iqvia-price-target-lowered-to-235-from-255-at-bofa-1034136090,neutral,0.6301711797714233
396,12/19/2024 5:44:17 PM,UBS’s global equity focus list: stocks within health technology,Seeking Alpha,https://seekingalpha.com/news/4388349-ubss-global-equity-focus-list-stocks-within-health-technology?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9390897750854492
397,12/19/2024 9:30:36 PM,Iqvia initiated with an Overweight at Stephens,TipRanks,/news/stocks/iqvia-initiated-with-an-overweight-at-stephens-1034158978,positive,0.850796103477478
398,1/10/2025 1:52:19 AM,RBC Capital Sticks to Their Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/rbc-capital-sticks-to-their-buy-rating-for-iqvia-holdings-iqv-1034212104,positive,0.5415299534797668
399,1/13/2025 2:15:23 PM,"Nvidia enters partnerships in healthcare, life sciences industry",TipRanks,/news/stocks/nvidia-enters-partnerships-in-healthcare-life-sciences-industry-1034222238,negative,0.7052655816078186
400,1/13/2025 2:15:59 PM,"Iqvia working with Nvidia to build custom models, agentic AI workflows",TipRanks,/news/stocks/iqvia-working-with-nvidia-to-build-custom-models-agentic-ai-workflows-1034222233,positive,0.8131784200668335
401,1/13/2025 2:25:28 PM,Iqvia announces strategic collaboration with Nvidia,TipRanks,/news/stocks/iqvia-announces-strategic-collaboration-with-nvidia-1034222196,negative,0.5861082673072815
402,1/13/2025 3:57:32 PM,"Nvidia partners with Illumina, IQVIA use generative AI to boost drug discovery",Seeking Alpha,https://seekingalpha.com/news/4394582-nvidia-partnerships-illumina-iqvia-use-generative-ai-boost-drug-discovery?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7775284051895142
403,1/15/2025 5:21:25 PM,Investors should look into pockets of opportunities in global equities – Harris Associates,Seeking Alpha,https://seekingalpha.com/news/4395374-investors-should-look-into-pockets-of-opportunities-in-global-equities-harris-associates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6976984143257141
404,1/21/2025 11:45:06 AM,Iqvia price target lowered to $210 from $212 at Baird,TipRanks,/news/stocks/iqvia-price-target-lowered-to-210-from-212-at-baird-1034249632,neutral,0.6742696166038513
405,2/3/2025 7:48:10 AM,IQVIA Holdings (IQV) Gets a Buy from Barclays,TipRanks,/news/stocks/iqvia-holdings-iqv-gets-a-buy-from-barclays-1034301723,positive,0.8026481866836548
406,2/3/2025 9:40:08 AM,Iqvia price target lowered to $235 from $255 at Barclays,TipRanks,/news/stocks/iqvia-price-target-lowered-to-235-from-255-at-barclays-1034302216,neutral,0.7939140200614929
407,2/3/2025 10:41:14 AM,Iqvia downgraded to Neutral from Buy at BTIG,TipRanks,/news/stocks/iqvia-downgraded-to-neutral-from-buy-at-btig-1034302374,positive,0.5990238785743713
408,2/4/2025 12:26:57 PM,Truist Financial Keeps Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/truist-financial-keeps-their-buy-rating-on-iqvia-holdings-iqv-1034308744,positive,0.9124823212623596
409,2/5/2025 11:00:46 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Amgen (AMGN) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-transmedics-group-tmdx-amgen-amgn-and-iqvia-holdings-iqv-1034314509,neutral,0.9294852614402771
410,2/5/2025 7:37:40 PM,IQVIA Q4 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4403847-iqvia-q4-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8849941492080688
411,2/6/2025 12:08:23 PM,IQVIA beats top-line and bottom-line estimates; reaffirms FY25 outlook,Seeking Alpha,https://seekingalpha.com/news/4404321-iqvia-beats-top-line-and-bottom-line-estimates-reaffirms-fy25-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8690914511680603
412,2/6/2025 12:30:12 PM,"Iqvia sees FY25 EPS $11.70- $12.10, consensus $11.88",TipRanks,/news/stocks/iqvia-sees-fy25-eps-11-70--12-10-consensus-11-88-1034322394,positive,0.5657004714012146
413,2/6/2025 12:31:47 PM,"Iqvia reports Q4 EPS  $3.12, consensus $3.11",TipRanks,/news/stocks/iqvia-reports-q4-eps-3-12-consensus-3-11-1034322384,positive,0.7579997777938843
414,2/6/2025 1:22:38 PM,"IQVIA Holdings Inc. Q4 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/iqvia-holdings-inc-q4-profit-decreases-but-beats-estimates-1034322095,neutral,0.9628974795341492
415,2/6/2025 2:03:42 PM,IQVIA Holdings Guides FY25 In Line With Estimates - Update ,RTTNews,/news/stocks/iqvia-holdings-guides-fy25-in-line-with-estimates-update-1034322513,positive,0.7680248618125916
416,2/7/2025 7:55:25 AM,Barclays Reaffirms Their Buy Rating on IQVIA Holdings (IQV),TipRanks,/news/stocks/barclays-reaffirms-their-buy-rating-on-iqvia-holdings-iqv-1034325896,positive,0.8556934595108032
417,2/7/2025 11:21:06 AM,"Analysts Are Neutral on Top Healthcare Stocks: IQVIA Holdings (IQV), Doximity (DOCS)",TipRanks,/news/stocks/analysts-are-neutral-on-top-healthcare-stocks-iqvia-holdings-iqv-doximity-docs-1034326670,positive,0.6895750761032104
418,2/7/2025 11:50:46 AM,"Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), X4 Pharmaceuticals (XFOR) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-illumina-ilmn-x4-pharmaceuticals-xfor-and-iqvia-holdings-iqv-1034326838,positive,0.9127432703971863
419,2/7/2025 12:31:21 PM,Iqvia price target raised to $220 from $210 at Baird,TipRanks,/news/stocks/iqvia-price-target-raised-to-220-from-210-at-baird-1034327199,negative,0.9381319284439087
420,2/7/2025 1:15:49 PM,Stifel Nicolaus Sticks to Its Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-buy-rating-for-iqvia-holdings-iqv-1034327493,positive,0.8230312466621399
421,2/7/2025 1:16:35 PM,TD Cowen Remains a Buy on IQVIA Holdings (IQV),TipRanks,/news/stocks/td-cowen-remains-a-buy-on-iqvia-holdings-iqv-1034327489,positive,0.9504864811897278
422,2/7/2025 2:03:48 PM,Iqvia price target raised to $260 from $250 at Deutsche Bank,TipRanks,/news/stocks/iqvia-price-target-raised-to-260-from-250-at-deutsche-bank-1034327819,negative,0.9444500207901001
423,2/7/2025 2:17:38 PM,Bank of America Securities Sticks to Its Buy Rating for IQVIA Holdings (IQV),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-its-buy-rating-for-iqvia-holdings-iqv-1034327908,positive,0.8797671794891357
